Physician profile
Preeti Saran
NPI 1417119728
$1,697.19
in general payments reported to CMS, 2019-2025
15 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $28.17 · 2020: $72.53 · 2021: $282 · 2022: $298 · 2023: $538 · 2024: $125 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,016.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,016.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $538.55 | 2021-2024 | Arexvy, Trelegy Ellipta |
| Novo Nordisk INC | $241.16 | 2019-2023 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $175.65 | 2023-2025 | Breztri, Wainua |
| Janssen Pharmaceuticals, INC | $134.05 | 2021-2022 | |
| Insmed, INC. | $126.63 | 2025 | Brinsupri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.75 | 2023 | Jardiance |
| Boston Scientific Corporation | $116.15 | 2025 | General - Therapies |
| Exact Sciences Corporation | $62.37 | 2023 | Cologuard Collection Kit |
| Lilly USA, LLC | $45.59 | 2019-2023 | Zepbound |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.32 | 2025 | Lifevest |
| Allergan, INC. | $28.91 | 2020 | |
| Inspire Medical Systems, INC. | $23.13 | 2025 | Inspire |
| Azurity Pharmaceuticals, INC. | $15.00 | 2023 | Edarbi |
| Merck Sharp & Dohme LLC | $14.95 | 2020 | |
| Sanofi-Aventis U.S. LLC | $12.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preeti Saran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.